<DOC>
	<DOCNO>NCT01089361</DOCNO>
	<brief_summary>The aim study assess effect short-term infusion ketamine analgesic dosage immune response , morbidity mortality among patient suffer septic shock . We hypothesize ketamine modulate cytokine response sepsis reduce morbidity mortality .</brief_summary>
	<brief_title>Immunomodulatory Properties Ketamine Sepsis</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Patients meet ACCP/ SCCM definition severe sepsis enrol study . These patient know suspected source infection . Patients within 12 hour development one organ dysfunction Patients must exhibit 3 follow sign clinical inflammation : Core temperature &lt; 36ºC &gt; 38ºC . Heart rate 90 great explain another medical condition . A respiratory rate &gt; 20 min1 , PaCO2 &lt; 32min1 need mechanical ventilation . A white blood cell count &lt; 4000 cell/ml &gt; 12000 cells/ml WBC show great 10 % immature neutrophil . pregnant increase intracranial pressure close head injury history psychotic mental disease receive Continuous Veno Venous Hemofiltration</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>systemic inflammatory syndrome</keyword>
	<keyword>sepsis syndrome</keyword>
	<keyword>septic shock</keyword>
	<keyword>Cytokine</keyword>
	<keyword>Ketamine</keyword>
</DOC>